Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pilot Growth Equity is a technology-focused growth equity firm investing in growth-stage private technology companies. They provide capital, operating expertise, and access to private/public sector customers, utilizing AI-driven deal sourcing. Their investment stages are typically Series B and Late Stage (Series C+), with investment tickets ranging from $10-50M. The firm's AUM is approximately $245M and they invest in founder-led companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pilot Growth Equity.